European Medical Solutions
XBRU:ALEMS
Balance Sheet
Balance Sheet Decomposition
European Medical Solutions
European Medical Solutions
Balance Sheet
European Medical Solutions
| Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
13
|
2
|
8
|
4
|
3
|
2
|
4
|
0
|
0
|
|
| Cash |
0
|
0
|
8
|
4
|
3
|
0
|
0
|
0
|
0
|
|
| Cash Equivalents |
13
|
2
|
0
|
0
|
0
|
2
|
4
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
8
|
7
|
7
|
8
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
12
|
13
|
16
|
13
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
2
|
3
|
3
|
8
|
|
| Total Current Assets |
14
|
2
|
9
|
4
|
3
|
24
|
27
|
32
|
34
|
|
| PP&E Net |
1
|
1
|
1
|
1
|
0
|
6
|
5
|
5
|
4
|
|
| PP&E Gross |
1
|
1
|
1
|
1
|
0
|
6
|
5
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
1
|
1
|
1
|
1
|
3
|
3
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
6
|
7
|
9
|
10
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
|
| Note Receivable |
1
|
1
|
2
|
2
|
2
|
0
|
0
|
0
|
0
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
0
|
|
| Total Assets |
16
N/A
|
4
-72%
|
12
+170%
|
7
-41%
|
5
-25%
|
36
+606%
|
40
+10%
|
51
+28%
|
48
-6%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
2
|
1
|
2
|
5
|
4
|
7
|
9
|
10
|
10
|
|
| Accrued Liabilities |
0
|
0
|
0
|
0
|
0
|
3
|
2
|
0
|
0
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
4
|
3
|
3
|
4
|
|
| Other Current Liabilities |
0
|
1
|
3
|
6
|
6
|
2
|
3
|
9
|
4
|
|
| Total Current Liabilities |
2
|
3
|
5
|
11
|
10
|
15
|
18
|
22
|
22
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
8
|
10
|
13
|
11
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
2
|
1
|
2
|
5
|
|
| Total Liabilities |
2
N/A
|
3
+27%
|
5
+65%
|
11
+116%
|
11
-2%
|
25
+137%
|
29
+15%
|
39
+33%
|
38
-3%
|
|
| Equity | ||||||||||
| Common Stock |
18
|
10
|
14
|
17
|
17
|
5
|
66
|
21
|
66
|
|
| Retained Earnings |
26
|
31
|
45
|
61
|
62
|
6
|
94
|
11
|
94
|
|
| Additional Paid In Capital |
22
|
22
|
37
|
39
|
39
|
0
|
39
|
2
|
39
|
|
| Other Equity |
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
0
|
|
| Total Equity |
13
N/A
|
1
-91%
|
6
+439%
|
4
N/A
|
6
-35%
|
11
N/A
|
11
-2%
|
12
+14%
|
10
-17%
|
|
| Total Liabilities & Equity |
16
N/A
|
4
-72%
|
12
+170%
|
7
-41%
|
5
-25%
|
36
+606%
|
40
+10%
|
51
+28%
|
48
-6%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
4
|
18
|
4
|
|